Bayer Schering Pharma paves the true way to another important oral contraceptive milestone Bayer Schering Pharma AG, Germany, offers submitted for sign up the initial combined oral contraceptive item predicated on estradiol and the progestin dienogest to all or any Member Claims of the European Community. HOLLAND will provide as the Reference Member Condition for the Decentralized Treatment to gain European-wide Advertising Authorization. This fresh oral contraceptive provides estradiol, the same estrogen made by the feminine body caverta dosage . Clinical analysis also demonstrated that new oral contraceptive includes a less pronounced effect on liver and metabolic parameters when compared to investigated comparators.

Other entries from category "treatments":

Random entries